Original paper
Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor
Abstract
There are conflicting clinical and laboratory data about the effect of dual antiplatelet therapy (DAPT) on cancer incidence, including analysis suggesting an increased cancer risk. This study aims to analyze if there are differences in the incidence of cancer according to the type of P2Y12 inhibitor prescribed (clopidogrel, prasugrel, or ticagrelor), among a population of acute coronary syndrome (ACS) survivors treated with DAPT.A retrospective...
Paper Details
Title
Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor
Published Date
Feb 1, 2019
Journal
Volume
174
Pages
51 - 58
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History